Skip to content

Alumis Inc. ALMS Restricted Cash

Restricted Cash at other companies

ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$36K+5.9%
Immunome logo
ImmunomeIMNM
$210K+110%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$259K-17.8%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$288K+28.0%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$5.81M+0.1%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$2.71M-0.1%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.12B+739%
Enterprise value$3.1B+1,238%
P/S371.9×

Profitability

See full
Operating margin-5,364%
Net margin-2,825.7%
FCF margin-4,487.4%

Returns & leverage

See full
Return on equity-64.6%
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alumis Inc.'s restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alumis Inc.'s restricted cash?
Alumis Inc. (ALMS) reported restricted cash of $86K in Q1 2026.
How has Alumis Inc.'s restricted cash changed year-over-year?
Alumis Inc.'s restricted cash decreased by 92.6% year-over-year, from $1.16M to $86K.
What is the long-term trend for Alumis Inc.'s restricted cash?
Over 2 years (2023 to 2025), Alumis Inc.'s restricted cash has grown at a -14.8% compound annual growth rate (CAGR), from $113K to $82K.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.